(18)F-FDG-PET/CT and (18)F-NaF-PET/CT in men with castrate-resistant prostate cancer

To evaluate (18)F-labeled-fluorodeoxyglucose ((18)F-FDG-) and (18)F-labeled-sodium fluoride ((18)F-NaF-) positron emission tomography/computed tomography (PET/CT) as biomarkers in metastatic castrate-resistant prostate cancer (mCRPC). Nine men (53-75 years) in a phase 1 trial of abiraterone and cabo...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Am J Nucl Med Mol Imaging
Auteurs principaux: Zukotynski, Katherine A, Kim, Chun K, Gerbaudo, Victor H, Hainer, Jon, Taplin, Mary-Ellen, Kantoff, Philip, den Abbeele, Annick D Van, Seltzer, Steven, Sweeney, Christopher J
Format: Artigo
Langue:Inglês
Publié: e-Century Publishing Corporation 2014
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4299771/
https://ncbi.nlm.nih.gov/pubmed/25625029
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires